{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:37:08Z","timestamp":1761100628470},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2003,5,1]],"date-time":"2003-05-01T00:00:00Z","timestamp":1051747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,5,1]],"date-time":"2003-05-01T00:00:00Z","timestamp":1051747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2003,5,1]]},"DOI":"10.1038\/sj.bmt.1704027","type":"journal-article","created":{"date-parts":[[2003,5,15]],"date-time":"2003-05-15T13:53:25Z","timestamp":1053006805000},"page":"877-887","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Allogeneic bone marrow transplantation for acute myeloblastic leukaemia in remission: risk factors for long-term morbidity and mortality"],"prefix":"10.1038","volume":"31","author":[{"given":"M","family":"Robin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Guardiola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Dombret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Baruchel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Esperou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Ribaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Devergie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Gluckman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Soci\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,5,15]]},"reference":[{"key":"BF1704027_CR1","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1056\/NEJM199501263320403","volume":"332","author":"RA Zittoun","year":"1995","unstructured":"Zittoun RA, Mandelli F, Willemze R et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups. N Engl J Med 1995; 332: 217\u2013223.","journal-title":"N Engl J Med"},{"key":"BF1704027_CR2","first-page":"2978","volume":"90","author":"JL Harousseau","year":"1997","unstructured":"Harousseau JL, Cahn JY, Pignon B et al. Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia. The Groupe Ouest Est Leucemies Aigues Myeloblastiques (GOELAM). Blood 1997; 90: 2978\u20132986.","journal-title":"Blood"},{"key":"BF1704027_CR3","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/S0140-6736(97)09214-3","volume":"351","author":"AK Burnett","year":"1998","unstructured":"Burnett AK, Goldstone AH, Stevens RM et al. Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Parties. Lancet 1998; 351: 700\u2013708.","journal-title":"Lancet"},{"key":"BF1704027_CR4","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1056\/NEJM199605303342203","volume":"334","author":"Y Ravindranath","year":"1996","unstructured":"Ravindranath Y, Yeager AM, Chang MN et al. Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group. N Engl J Med 1996; 334: 1428\u20131434.","journal-title":"N Engl J Med"},{"key":"BF1704027_CR5","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1200\/JCO.1993.11.6.1046","volume":"11","author":"S Amadori","year":"1993","unstructured":"Amadori S, Testi AM, Arico M et al. Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia. The Associazione Italiana Ematologia ed Oncologia Pediatrica Cooperative Group. J Clin Oncol 1993; 11: 1046\u20131054.","journal-title":"J Clin Oncol"},{"key":"BF1704027_CR6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1182\/blood.V97.1.56","volume":"97","author":"WG Woods","year":"2001","unstructured":"Woods WG, Neudorf S, Gold S et al. A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission: a report from the Children's cancer group. Blood 2001; 97: 56\u201362.","journal-title":"Blood"},{"key":"BF1704027_CR7","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1056\/NEJM199812033392301","volume":"339","author":"PA Cassileth","year":"1998","unstructured":"Cassileth PA, Harrington DP, Appelbaum FR et al. Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission [see comments]. N Engl J Med 1998; 339: 1649\u20131656.","journal-title":"N Engl J Med"},{"key":"BF1704027_CR8","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1038\/sj.leu.2401859","volume":"14","author":"P Fenaux","year":"2000","unstructured":"Fenaux P, Chevret S, Guerci A et al. Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia. European APL group. Leukemia 2000; 14: 1371\u20131377.","journal-title":"Leukemia"},{"key":"BF1704027_CR9","first-page":"964","volume":"10","author":"P Anderlini","year":"1996","unstructured":"Anderlini P, Ghaddar HM, Smith TL et al. Factors predicting complete remission and subsequent disease-free survival after a second course of induction therapy in patients with acute myelogenous leukemia resistant to the first. Leukemia 1996; 10: 964\u2013996.","journal-title":"Leukemia"},{"key":"BF1704027_CR10","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1200\/JCO.1988.6.2.232","volume":"6","author":"HM Kantarjian","year":"1988","unstructured":"Kantarjian HM, Keating MJ, Walters RS et al. The characteristics and outcome of patients with late relapse acute myelogenous leukemia. J Clin Oncol 1988; 6: 232\u2013238.","journal-title":"J Clin Oncol"},{"key":"BF1704027_CR11","first-page":"203","volume":"16","author":"RP Gale","year":"1995","unstructured":"Gale RP, Horowitz MM, Weiner RS et al. Impact of cytogenetic abnormalities on outcome of bone marrow transplants in acute myelogenous leukemia in first remission. Bone Marrow Transplant 1995; 16: 203\u2013208.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704027_CR12","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1182\/blood.V75.10.1932.1932","volume":"75","author":"U Creutzig","year":"1990","unstructured":"Creutzig U, Ritter J, Schellong G . Identification of two risk groups in childhood acute myelogenous leukemia after therapy intensification in study AML-BFM-83 as compared with study AML-BFM-78. AML-BFM Study Group. Blood 1990; 75: 1932\u20131940.","journal-title":"Blood"},{"key":"BF1704027_CR13","first-page":"191","volume":"17","author":"G Michel","year":"1996","unstructured":"Michel G, Leverger G, Leblanc T et al. Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP). Bone Marrow Transplant 1996; 17: 191\u2013196.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704027_CR14","first-page":"13","volume":"17","author":"F Frassoni","year":"1996","unstructured":"Frassoni F, Labopin M, Gluckman E et al. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time\u2014a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT). Bone Marrow Transplant 1996; 17: 13\u201318.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704027_CR15","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1001\/jama.1992.03490050055025","volume":"268","author":"MM Bortin","year":"1992","unstructured":"Bortin MM, Horowitz MM, Gale RP et al. Changing trends in allogeneic bone marrow transplantation for leukemia in the 1980s. JAMA 1992; 268: 607\u2013612.","journal-title":"JAMA"},{"key":"BF1704027_CR16","first-page":"250","volume":"28","author":"KM Sullivan","year":"1991","unstructured":"Sullivan KM, Agura E, Anasetti C et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol 1991; 28: 250\u2013259.","journal-title":"Semin Hematol"},{"key":"BF1704027_CR17","first-page":"1019","volume":"16","author":"IA Tabbara","year":"1996","unstructured":"Tabbara IA . Allogeneic bone marrow transplantation: acute and late complications. Anticancer Res 1996; 16: 1019\u20131026.","journal-title":"Anticancer Res"},{"key":"BF1704027_CR18","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/00001622-199004000-00009","volume":"2","author":"HJ Deeg","year":"1990","unstructured":"Deeg HJ . Early and late complications of bone marrow transplantation. Curr Opin Oncol 1990; 2: 297\u2013307.","journal-title":"Curr Opin Oncol"},{"key":"BF1704027_CR19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1056\/NEJM199907013410103","volume":"341","author":"G Socie","year":"1999","unstructured":"Socie G, Stone JV, Wingard JR et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med 1999; 341: 14\u201321.","journal-title":"N Engl J Med"},{"key":"BF1704027_CR20","first-page":"297","volume":"32","author":"S Castaigne","year":"1990","unstructured":"Castaigne S, Chevret S, Lepage E et al. Prognostic factors of acute non lymphoblastic leukemia in children and adults. Results from two multicentric trials (705 patients). Nouv Rev Fr Hematol 1990; 32: 297\u2013300.","journal-title":"Nouv Rev Fr Hematol"},{"key":"BF1704027_CR21","first-page":"S139","volume":"36","author":"S Castaigne","year":"1994","unstructured":"Castaigne S, Archimbaud E, Fenaux P et al. Role of double induction in the treatment of acute myeloblastic leukemia in the adult: intermediate results of protocol LAM90. Nouv Rev Fr Hematol 1994; 36: S139\u2013S140.","journal-title":"Nouv Rev Fr Hematol"},{"key":"BF1704027_CR22","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00282-996-0169-7","volume":"38","author":"G Michel","year":"1996","unstructured":"Michel G, Baruchel A, Tabone MD et al. Induction chemotherapy followed by allogeneic bone marrow transplantation or aggressive consolidation chemotherapy in childhood acute myeloblastic leukemia. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP). Hematol Cell Ther 1996; 38: 169\u2013176.","journal-title":"Hematol Cell Ther"},{"key":"BF1704027_CR23","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/j.1365-2141.1989.tb04325.x","volume":"72","author":"R Storb","year":"1989","unstructured":"Storb R, Deeg HJ, Pepe M et al. Graft-versus-host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long-term follow-up of a controlled trial [see comments]. Br J Haematol 1989; 72: 567\u2013572.","journal-title":"Br J Haematol"},{"key":"BF1704027_CR24","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1182\/blood.V73.6.1729.1729","volume":"73","author":"R Storb","year":"1989","unstructured":"Storb R, Deeg HJ, Pepe M et al. Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial. Blood 1989; 73: 1729\u20131734.","journal-title":"Blood"},{"key":"BF1704027_CR25","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","volume":"69","author":"HM Shulman","year":"1980","unstructured":"Shulman HM, Sullivan KM, Weiden PL et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204\u2013217.","journal-title":"Am J Med"},{"key":"BF1704027_CR26","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","volume":"18","author":"H Glucksberg","year":"1974","unstructured":"Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295\u2013304.","journal-title":"Transplantation"},{"key":"BF1704027_CR27","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1182\/blood.V88.10.4063.bloodjournal88104063","volume":"88","author":"M Boeckh","year":"1996","unstructured":"Boeckh M, Gooley TA, Myerson D et al. Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study. Blood 1996; 88: 4063\u20134071.","journal-title":"Blood"},{"key":"BF1704027_CR28","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1093\/infdis\/153.3.478","volume":"153","author":"JD Meyers","year":"1986","unstructured":"Meyers JD, Flournoy N, Thomas ED . Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis 1986; 153: 478\u2013488.","journal-title":"J Infect Dis"},{"key":"BF1704027_CR29","first-page":"243","volume":"2","author":"RA Clift","year":"1987","unstructured":"Clift RA, Buckner CD, Thomas ED et al. The treatment of acute non-lymphoblastic leukemia by allogeneic marrow transplantation. Bone Marrow Transplant 1987; 2: 243\u2013258.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704027_CR30","first-page":"2931","volume":"90","author":"A Ferrant","year":"1997","unstructured":"Ferrant A, Labopin M, Frassoni F et al. Karyotype in acute myeloblastic leukemia: prognostic significance for bone marrow transplantation in first remission: a European Group for Blood and Marrow Transplantation study. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Blood 1997; 90: 2931\u20132938.","journal-title":"Blood"},{"key":"BF1704027_CR31","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1200\/JCO.1993.11.8.1448","volume":"11","author":"WG Woods","year":"1993","unstructured":"Woods WG, Kobrinsky N, Buckley J et al. Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: a Childrens Cancer Group pilot study. J Clin Oncol 1993; 11: 1448\u20131457.","journal-title":"J Clin Oncol"},{"key":"BF1704027_CR32","first-page":"403","volume":"2","author":"MJ Keating","year":"1988","unstructured":"Keating MJ, Smith TL, Kantarjian H et al. Cytogenetic pattern in acute myelogenous leukemia: a major reproducible determinant of outcome. Leukemia 1988; 2: 403\u2013412.","journal-title":"Leukemia"},{"key":"BF1704027_CR33","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1182\/blood.V72.5.1512.1512","volume":"72","author":"PB McGlave","year":"1988","unstructured":"McGlave PB, Haake RJ, Bostrom BC et al. Allogeneic bone marrow transplantation for acute nonlymphocytic leukemia in first remission. Blood 1988; 72: 1512\u20131517.","journal-title":"Blood"},{"key":"BF1704027_CR34","first-page":"993","volume":"17","author":"S Keating","year":"1996","unstructured":"Keating S, Suciu S, de Witte T et al. Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission: an analysis of the EORTC- GIMEMA AML 8A trial. The European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto (GIMEMA) Leukemia Cooperative Groups. Bone Marrow Transplant 1996; 17: 993\u20131001.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704027_CR35","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1200\/JCO.1989.7.3.326","volume":"7","author":"MS Tallman","year":"1989","unstructured":"Tallman MS, Kopecky KJ, Amos D et al. Analysis of prognostic factors for the outcome of marrow transplantation or further chemotherapy for patients with acute nonlymphocytic leukemia in first remission. J Clin Oncol 1989; 7: 326\u2013337.","journal-title":"J Clin Oncol"},{"key":"BF1704027_CR36","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1056\/NEJM199410063311402","volume":"331","author":"RJ Mayer","year":"1994","unstructured":"Mayer RJ, Davis RB, Schiffer CA et al. Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B [see comments]. N Engl J Med 1994; 331: 896\u2013903.","journal-title":"N Engl J Med"},{"key":"BF1704027_CR37","first-page":"1254","volume":"96","author":"MS Tallman","year":"2000","unstructured":"Tallman MS, Rowlings PA, Milone G et al. Effect of postremission chemotherapy before human leukocyte antigen- identical sibling transplantation for acute myelogenous leukemia in first complete remission. Blood 2000; 96: 1254\u20131258.","journal-title":"Blood"},{"key":"BF1704027_CR38","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1046\/j.1365-2141.2000.02178.x","volume":"110","author":"JY Cahn","year":"2000","unstructured":"Cahn JY, Labopin M, Sierra J et al. No impact of high-dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remission. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Br J Haematol 2000; 110: 308\u2013314.","journal-title":"Br J Haematol"},{"key":"BF1704027_CR39","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1023\/A:1008267904952","volume":"8","author":"M Fopp","year":"1997","unstructured":"Fopp M, Fey MF, Bacchi M et al. Post-remission therapy of adult acute myeloid leukaemia: one cycle of high-dose versus standard-dose cytarabine. Leukaemia Project Group of the Swiss Group for Clinical Cancer Research (SAKK). Ann Oncol 1997; 8: 251\u2013257.","journal-title":"Ann Oncol"},{"key":"BF1704027_CR40","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1182\/blood.V79.8.1924.1924","volume":"79","author":"PA Cassileth","year":"1992","unstructured":"Cassileth PA, Lynch E, Hines JD et al. Varying intensity of postremission therapy in acute myeloid leukemia. Blood 1992; 79: 1924\u20131930.","journal-title":"Blood"},{"key":"BF1704027_CR41","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/sj.bmt.1700761","volume":"19","author":"E Jourdan","year":"1997","unstructured":"Jourdan E, Maraninchi D, Reiffers J et al. Early allogeneic transplantation favorably influences the outcome of adult patients suffering from acute myeloid leukemia. Societe Francaise de Greffe de Moelle (SFGM). Bone Marrow Transplant 1997; 19: 875\u2013881.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704027_CR42","first-page":"257","volume":"3","author":"GR Hill","year":"1997","unstructured":"Hill GR, Krenger W, Ferrara JL . The role of cytokines in acute graft-versus-host disease. Cytokines Cell Mol Ther 1997; 3: 257\u2013266.","journal-title":"Cytokines Cell Mol Ther"},{"key":"BF1704027_CR43","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1097\/00007890-199708270-00001","volume":"64","author":"W Krenger","year":"1997","unstructured":"Krenger W, Hill GR, Ferrara JL . Cytokine cascades in acute graft-versus-host disease. Transplantation 1997; 64: 553\u2013558.","journal-title":"Transplantation"},{"key":"BF1704027_CR44","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3928\/0090-4481-19911201-06","volume":"20","author":"JE Sanders","year":"1991","unstructured":"Sanders JE . Bone marrow transplantation for pediatric leukemia. Pediatr Ann 1991; 20: 671\u2013676.","journal-title":"Pediatr Ann"},{"key":"BF1704027_CR45","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1056\/NEJM199703273361301","volume":"336","author":"RE Curtis","year":"1997","unstructured":"Curtis RE, Rowlings PA, Deeg HJ et al. Solid cancers after bone marrow transplantation [see comments]. N Engl J Med 1997; 336: 897\u2013904.","journal-title":"N Engl J Med"},{"key":"BF1704027_CR46","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1182\/blood.V91.10.3637","volume":"91","author":"HJ Deeg","year":"1998","unstructured":"Deeg HJ, Leisenring W, Storb R et al. Long-term outcome after marrow transplantation for severe aplastic anemia. Blood 1998; 91: 3637\u20133645.","journal-title":"Blood"},{"key":"BF1704027_CR47","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1182\/blood.V87.9.3633.bloodjournal8793633","volume":"87","author":"S Bhatia","year":"1996","unstructured":"Bhatia S, Ramsay NK, Steinbuch M et al. Malignant neoplasms following bone marrow transplantation. Blood 1996; 87: 3633\u20133639.","journal-title":"Blood"},{"key":"BF1704027_CR48","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.1182\/blood.V95.12.3683","volume":"95","author":"S Kulkarni","year":"2000","unstructured":"Kulkarni S, Powles R, Treleaven J et al. Chronic graft versus host disease is associated with long-term risk for pneumococcal infections in recipients of bone marrow transplants. Blood 2000; 95: 3683\u20133686.","journal-title":"Blood"},{"key":"BF1704027_CR49","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1200\/JCO.1994.12.9.1923","volume":"12","author":"SA Giralt","year":"1994","unstructured":"Giralt SA, LeMaistre CF, Vriesendorp HM et al. Etoposide, cyclophosphamide, total-body irradiation, and allogeneic bone marrow transplantation for hematologic malignancies. J Clin Oncol 1994; 12: 1923\u20131930.","journal-title":"J Clin Oncol"},{"key":"BF1704027_CR50","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/ajh.2830410108","volume":"41","author":"JC Yau","year":"1992","unstructured":"Yau JC, LeMaistre CF, Andersson BS et al. Allogeneic bone marrow transplantation for hematological malignancies following etoposide, cyclophosphamide, and fractionated total body irradiation. Am J Hematol 1992; 41: 40\u201344.","journal-title":"Am J Hematol"},{"key":"BF1704027_CR51","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1182\/blood.V76.9.1867.1867","volume":"76","author":"RA Clift","year":"1990","unstructured":"Clift RA, Buckner CD, Appelbaum FR et al. Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens. Blood 1990; 76: 1867\u20131871.","journal-title":"Blood"},{"key":"BF1704027_CR52","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1097\/00007890-198806000-00018","volume":"45","author":"A Bacigalupo","year":"1988","unstructured":"Bacigalupo A, Van Lint MT, Occhini D et al. ABO compatibility and acute graft-versus-host disease following allogeneic bone marrow transplantation. Transplantation 1988; 45: 1091\u20131094.","journal-title":"Transplantation"},{"key":"BF1704027_CR53","first-page":"741","volume":"18","author":"J Mehta","year":"1996","unstructured":"Mehta J, Powles R, Treleaven J et al. Long-term follow-up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide-total body irradiation and cyclosporine. Bone Marrow Transplant 1996; 18: 741\u2013746.","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl. 2","key":"BF1704027_CR54","first-page":"S25","volume":"25","author":"DJ Winston","year":"1989","unstructured":"Winston DJ, Ho WG, Champlin RE . Current approaches to management of infections in bone marrow transplants. Eur J Cancer Clin Oncol 1989; 25 (Suppl. 2): S25\u2013S35.","journal-title":"Eur J Cancer Clin Oncol"},{"key":"BF1704027_CR55","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1086\/516480","volume":"175","author":"A Wald","year":"1997","unstructured":"Wald A, Leisenring W, van Burik JA, Bowden RA . Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation [see comments]. J Infect Dis 1997; 175: 1459\u20131466.","journal-title":"J Infect Dis"},{"key":"BF1704027_CR56","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/clinids\/17.3.397","volume":"17","author":"PH McWhinney","year":"1993","unstructured":"McWhinney PH, Kibbler CC, Hamon MD et al. Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years' experience. Clin Infect Dis 1993; 17: 397\u2013404.","journal-title":"Clin Infect Dis"},{"key":"BF1704027_CR57","first-page":"175","volume":"2","author":"JR Wingard","year":"1987","unstructured":"Wingard JR, Beals SU, Santos GW et al. Aspergillus infections in bone marrow transplant recipients. Bone Marrow Transplant 1987; 2: 175\u2013181.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704027_CR58","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1200\/JCO.1997.15.6.2238","volume":"15","author":"G Michel","year":"1997","unstructured":"Michel G, Socie G, Gebhard F et al. Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: the impact of conditioning regimen without total-body irradiation\u2014a report from the Societe Francaise de Greffe de Moelle. J Clin Oncol 1997; 15: 2238\u20132246.","journal-title":"J Clin Oncol"},{"key":"BF1704027_CR59","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1182\/blood.V68.5.1129.1129","volume":"68","author":"JE Sanders","year":"1986","unstructured":"Sanders JE, Pritchard S, Mahoney P et al. Growth and development following marrow transplantation for leukemia. Blood 1986; 68: 1129\u20131135.","journal-title":"Blood"},{"key":"BF1704027_CR60","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/sj.bmt.1701769","volume":"23","author":"A Cohen","year":"1999","unstructured":"Cohen A, Duell T, Socie G et al. Nutritional status and growth after bone marrow transplantation (BMT) during childhood: EBMT Late-Effects Working Party retrospective data. European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1999; 23: 1043\u20131047.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704027_CR61","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1182\/blood.V93.6.2013.406k25_2013_2024","volume":"93","author":"A Cohen","year":"1999","unstructured":"Cohen A, Rovelli A, Bakker B et al. Final height of patients who underwent bone marrow transplantation for hematological disorders during childhood: a study by the Working Party for Late Effects-EBMT. Blood 1999; 93: 4109\u20134115.","journal-title":"Blood"},{"key":"BF1704027_CR62","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1086\/515146","volume":"28","author":"Q Nguyen","year":"1999","unstructured":"Nguyen Q, Champlin R, Giralt S et al. Late cytomegalovirus pneumonia in adult allogeneic blood and marrow transplant recipients. Clin Infect Dis 1999; 28: 618\u2013623.","journal-title":"Clin Infect Dis"},{"key":"BF1704027_CR63","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/S0140-6736(94)91835-X","volume":"343","author":"HG Prentice","year":"1994","unstructured":"Prentice HG, Gluckman E, Powles RL et al. Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study Group. Lancet 1994; 343: 749\u2013753.","journal-title":"Lancet"},{"key":"BF1704027_CR64","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/sj.bmt.1700498","volume":"19","author":"HG Prentice","year":"1997","unstructured":"Prentice HG, Gluckman E, Powles RL et al. Long-term survival in allogeneic bone marrow transplant recipients following acyclovir prophylaxis for CMV infection. The European Acyclovir for CMV Prophylaxis Study Group. Bone Marrow Transplant 1997; 19: 129\u2013133.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704027_CR65","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/sj.bmt.1702190","volume":"25","author":"CB Steer","year":"2000","unstructured":"Steer CB, Szer J, Sasadeusz J et al. Varicella-zoster infection after allogeneic bone marrow transplantation: incidence, risk factors and prevention with low-dose aciclovir and ganciclovir. Bone Marrow Transplant 2000; 25: 657\u2013664.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704027_CR66","first-page":"277","volume":"13","author":"CS Han","year":"1994","unstructured":"Han CS, Miller W, Haake R, Weisdorf D . Varicella zoster infection after bone marrow transplantation: incidence, risk factors and complications. Bone Marrow Transplant 1994; 13: 277\u2013283.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704027_CR67","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/00007890-198001000-00010","volume":"29","author":"K Atkinson","year":"1980","unstructured":"Atkinson K, Meyers JD, Storb R et al. Varicella-zoster virus infection after marrow transplantation for aplastic anemia or leukemia. Transplantation 1980; 29: 47\u201350.","journal-title":"Transplantation"},{"key":"BF1704027_CR68","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1093\/infdis\/152.6.1172","volume":"152","author":"RM Locksley","year":"1985","unstructured":"Locksley RM, Flournoy N, Sullivan KM, Meyers JD . Infection with varicella-zoster virus after marrow transplantation. J Infect Dis 1985; 152: 1172\u20131181.","journal-title":"J Infect Dis"},{"key":"BF1704027_CR69","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1365-2141.1984.tb02887.x","volume":"57","author":"HJ Deeg","year":"1984","unstructured":"Deeg HJ, Storb R, Thomas ED . Bone marrow transplantation: a review of delayed complications. Br J Haematol 1984; 57: 185\u2013208.","journal-title":"Br J Haematol"},{"key":"BF1704027_CR70","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/bjc.1989.88","volume":"59","author":"PJ Selby","year":"1989","unstructured":"Selby PJ, Powles RL, Easton D et al. The prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantation. Br J Cancer 1989; 59: 434\u2013438.","journal-title":"Br J Cancer"},{"key":"BF1704027_CR71","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1182\/blood.V86.2.819.bloodjournal862819","volume":"86","author":"Z Huma","year":"1995","unstructured":"Huma Z, Boulad F, Black P et al. Growth in children after bone marrow transplantation for acute leukemia. Blood 1995; 86: 819\u2013824.","journal-title":"Blood"},{"key":"BF1704027_CR72","first-page":"157","volume":"21","author":"C Uderzo","year":"2000","unstructured":"Uderzo C, Biagi E, Rovelli A et al. Bone marrow transplantation for childhood hematological disorders: a global pediatric approach in a twelve year single center experience. Pediatr Med Chir 2000; 21: 157\u2013163.","journal-title":"Pediatr Med Chir"},{"key":"BF1704027_CR73","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/(SICI)1096-911X(199903)32:3<163::AID-MPO1>3.0.CO;2-#","volume":"32","author":"AM Leahey","year":"1999","unstructured":"Leahey AM, Teunissen H, Friedman DL et al. Late effects of chemotherapy compared to bone marrow transplantation in the treatment of pediatric acute myeloid leukemia and myelodysplasia. Med Pediatr Oncol 1999; 32: 163\u2013169.","journal-title":"Med Pediatr Oncol"},{"key":"BF1704027_CR74","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(00)02709-4","volume":"356","author":"G Socie","year":"2000","unstructured":"Socie G . Is syndrome \u2018X\u2019 another late complication of bone-marrow transplantation?. Lancet 2000; 356: 957\u2013958.","journal-title":"Lancet"},{"key":"BF1704027_CR75","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1200\/JCO.2000.18.2.348","volume":"18","author":"G Socie","year":"2000","unstructured":"Socie G, Curtis RE, Deeg HJ et al. New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. J Clin Oncol 2000; 18: 348\u2013357.","journal-title":"J Clin Oncol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1704027","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704027.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704027.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T23:25:46Z","timestamp":1648077946000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1704027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5,1]]},"references-count":75,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2003,5,1]]}},"alternative-id":["BF1704027"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1704027","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,5,1]]},"assertion":[{"value":"2 May 2002","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2002","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2003","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}